KCNK9 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-17267
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Summary for KCNK9 Antibody
Immunogen
This antibody was developed against Recombinant Protein corresponding to amino acids: LESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEP
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for KCNK9 Antibody
Immunocytochemistry/ Immunofluorescence: KCNK9 Antibody [NBP3-17267]
Immunocytochemistry/Immunofluorescence: KCNK9 Antibody [NBP3-17267] - Staining of human cell line SH-SY5Y shows localization to plasma membrane.Applications for KCNK9 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Immunocytochemistry/Immunofluorescence, PFA/Triton X-100 is recommended for fixation/permeabilization.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: KCNK9
Long Name
Potassium channel subfamily K member 9
Alternate Names
TASK3
Gene Symbol
KCNK9
Additional KCNK9 Products
Product Documents for KCNK9 Antibody
Product Specific Notices for KCNK9 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...